Loading clinical trials...
Loading clinical trials...
This study will investigate the application of a vasopressin antagonist in the treatment of hyponatremia most likely caused by inappropriate AVP secretion. The population studied will include patients...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Cumberland Pharmaceuticals
NCT06408077 · Hyponatremia
NCT05542056 · Thiazide-induced Hyponatremia (TIH)
NCT07430787 · Hyponatremia, Osmotic Demyelination Syndrome, and more
NCT07255833 · Hyponatremia
NCT03557957 · Hyponatremia
Tuscon, Arizona
Denver, Colorado
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions